Design and Analysis of Cross-Over Trials, Second Edition

الغلاف الأمامي
Taylor & Francis, 12‏/03‏/2003 - 408 من الصفحات

The first edition of Design and Analysis of Cross-Over Trials quickly became the standard reference on the subject and has remained so for more than 12 years. In that time, however, the use of cross-over trials has grown rapidly, particularly in the pharmaceutical arena, and researchers have made a number of advances in both the theory and methods applicable to these trials.

Completely revised and updated, the long-awaited second edition of this classic text retains its predecessor's careful balance of theory and practice while incorporating new approaches, more data sets, and a broader scope. Enhancements in the second edition include:

  • A new chapter on bioequivalence
  • Recently developed methods for analyzing longitudinal continuous and categorical data
  • Real-world examples using the SAS system
  • A comprehensive catalog of designs, datasets, and SAS programs available on a companion Web site at www.crcpress.com

The authors' exposition gives a clear, unified account of the design and analysis of cross-over trials from a statistical perspective along with their methodological underpinnings. With SAS programs and a thorough treatment of design issues, Design and Analysis of Cross-Over Trials, Second Edition sets a new standard for texts in this area and undoubtedly will be of direct practical value for years to come.

طبعات أخرى - عرض جميع المقتطفات

نبذة عن المؤلف (2003)

Jones is Director of the Research Statistics Unit, GlaxoSmithKline Pharmaceuticals, Essex, UK.

Kenward is GSK Professor of Biostatistics at the London School of Hygiene and Tropical Medicine, London, UK.

معلومات المراجع